Sean is a JDM and off-road enthusiast of many years, and automotive photographer. He holds a B.A. in Literature and Writing Studies, A.A. in Communications, and an A.A. in English. He is published in ...

While the Outback is Subaru's answer to the declining wagon genre in the United States, the Forester fits right into the country's expanding SUV market as the brand's versatile family SUV with room ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...

A Civil Engineer turned Automotive Journalist, Ritesh Patil started his journey in this field in 2022. He has ridden a variety of motorcycles - from an entry-level Kawasaki W175 to the manic Ducati ...

Sean is a JDM and off-road enthusiast of many years, and automotive photographer. He holds a B.A. in Literature and Writing Studies, A.A. in Communications, and an A.A. in English. He is published in ...

Are you having problems with your 2026 Subaru Crosstrek? Let our team of motoring experts keep you up to date with all of the latest 2026 Subaru Crosstrek issues & faults. We have gathered all of the ...

After 36 years of continuous production, the final Subaru Legacy has rolled off the assembly line at Subaru of Indiana Automotive (SIA) in Lafayette, Indiana. The milestone, which took place earlier ...

Paul Merson reckons Liverpool have a simple solution for their Florian Wirtz problem, but this impulsive idea would fail for two reasons… Wirtz ‘will be a flop until he’s not’ following his mega-money ...

“The problem that Powell faces right now is a very difficult one,” Wolfers said in an MSNBC interview last week. “It is that tariffs have caused a slowdown in economic activity and rising unemployment ...

Merck (NYSE:MRK) said that the FDA has cleared Keytruda Qlex, a new subcutaneous version of its blockbuster cancer drug, offering a faster alternative to IV infusion, a company spokesperson confirmed ...